4//SEC Filing
PENDARVIS DAVID 4
Accession 0001127602-23-014596
CIK 0000943819other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 7:49 PM ET
Size
4.4 KB
Accession
0001127602-23-014596
Insider Transaction Report
Form 4
RESMED INCRMD
PENDARVIS DAVID
Sr. VP, General Counsel
Transactions
- Sale
ResMed Common Stock
2023-05-03$237.64/sh−1,500$356,460→ 91,172 total
Footnotes (1)
- [F1]The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2022.
Documents
Issuer
RESMED INC
CIK 0000943819
Entity typeother
Related Parties
1- filerCIK 0001196723
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 7:49 PM ET
- Size
- 4.4 KB